109 related articles for article (PubMed ID: 21307612)
21. Endothelial‑like cells differentiated from mesenchymal stem cells attenuate neointimal hyperplasia after vascular injury.
Xu J; Wu D; Yang Y; Ji K; Gao P
Mol Med Rep; 2016 Nov; 14(5):4830-4836. PubMed ID: 27748807
[TBL] [Abstract][Full Text] [Related]
22. Crucial role of nuclear factor-kappaB in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow.
Squadrito F; Deodato B; Bova A; Marini H; Saporito F; Calò M; Giacca M; Minutoli L; Venuti FS; Caputi AP; Altavilla D
Atherosclerosis; 2003 Feb; 166(2):233-42. PubMed ID: 12535735
[TBL] [Abstract][Full Text] [Related]
23. Cathepsin S Deficiency Mitigated Chronic Stress-Related Neointimal Hyperplasia in Mice.
Wang H; Meng X; Piao L; Inoue A; Xu W; Yu C; Nakamura K; Hu L; Sasaki T; Wu H; Unno K; Umegaki H; Murohara T; Shi GP; Kuzuya M; Cheng XW
J Am Heart Assoc; 2019 Jul; 8(14):e011994. PubMed ID: 31296090
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of mesenchymal stem cells in intimal hyperplasia after balloon angioplasty.
Kim AK; Kim MH; Kim DH; Go HN; Cho SW; Um SH; Kim DI
J Vasc Surg; 2016 Feb; 63(2):510-7. PubMed ID: 25240243
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1 receptor antagonist originating from bone marrowderived cells and non-bone marrow-derived cells helps to suppress arterial inflammation and reduce neointimal formation after injury.
Isoda K; Akita K; Isobe S; Niida T; Adachi T; Iwakura Y; Daida H
J Atheroscler Thromb; 2014; 21(11):1208-18. PubMed ID: 25223697
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
[TBL] [Abstract][Full Text] [Related]
27. Empagliflozin inhibits neointimal hyperplasia through attenuating endothelial-to-mesenchymal transition via TAK-1/NF-κB pathway.
Zhang W; Li X; Li M; He H; Yang C; Wang M; Liu D; Zhang L; Shu C
Eur J Pharmacol; 2023 Sep; 954():175826. PubMed ID: 37321472
[TBL] [Abstract][Full Text] [Related]
28. Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model.
Sepúlveda JC; Tomé M; Fernández ME; Delgado M; Campisi J; Bernad A; González MA
Stem Cells; 2014 Jul; 32(7):1865-77. PubMed ID: 24496748
[TBL] [Abstract][Full Text] [Related]
29. Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model.
Makino Y; Miyahara T; Nitta J; Miyahara K; Seo A; Kimura M; Suhara M; Akai A; Akagi D; Yamamoto K; Hoshina K
J Surg Res; 2019 Jan; 233():104-110. PubMed ID: 30502235
[TBL] [Abstract][Full Text] [Related]
30. Metformin Augments Anti-Inflammatory and Chondroprotective Properties of Mesenchymal Stem Cells in Experimental Osteoarthritis.
Park MJ; Moon SJ; Baek JA; Lee EJ; Jung KA; Kim EK; Kim DS; Lee JH; Kwok SK; Min JK; Kim SJ; Park SH; Cho ML
J Immunol; 2019 Jul; 203(1):127-136. PubMed ID: 31142603
[TBL] [Abstract][Full Text] [Related]
31. Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.
Moon GJ; Cho YH; Kim DH; Sung JH; Son JP; Kim S; Cha JM; Bang OY
Cell Transplant; 2018 Mar; 27(3):485-500. PubMed ID: 29774769
[TBL] [Abstract][Full Text] [Related]
32. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
33. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
[TBL] [Abstract][Full Text] [Related]
34. Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury.
Tian Z; Miyata K; Tazume H; Sakaguchi H; Kadomatsu T; Horio E; Takahashi O; Komohara Y; Araki K; Hirata Y; Tabata M; Takanashi S; Takeya M; Hao H; Shimabukuro M; Sata M; Kawasuji M; Oike Y
J Mol Cell Cardiol; 2013 Apr; 57():1-12. PubMed ID: 23333801
[TBL] [Abstract][Full Text] [Related]
35. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
[TBL] [Abstract][Full Text] [Related]
36. Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.
Takigawa T; Tsurushima H; Suzuki K; Tsuruta W; Nakamura K; Matsumura A
J Vasc Surg; 2012 Feb; 55(2):506-16. PubMed ID: 22264805
[TBL] [Abstract][Full Text] [Related]
37. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6.
Roddy GW; Oh JY; Lee RH; Bartosh TJ; Ylostalo J; Coble K; Rosa RH; Prockop DJ
Stem Cells; 2011 Oct; 29(10):1572-9. PubMed ID: 21837654
[TBL] [Abstract][Full Text] [Related]
38. The origin of human mesenchymal stromal cells dictates their reparative properties.
Naftali-Shani N; Itzhaki-Alfia A; Landa-Rouben N; Kain D; Holbova R; Adutler-Lieber S; Molotski N; Asher E; Grupper A; Millet E; Tessone A; Winkler E; Kastrup J; Feinberg MS; Zipori D; Pevsner-Fischer M; Raanani E; Leor J
J Am Heart Assoc; 2013 Sep; 2(5):e000253. PubMed ID: 24080908
[TBL] [Abstract][Full Text] [Related]
39. DNA enzyme ED5 depletes egr-1 and inhibits neointimal hyperplasia in rats.
Wang TR; Yang G; Liu GN
Cardiology; 2013; 125(3):192-200. PubMed ID: 23774133
[TBL] [Abstract][Full Text] [Related]
40. Monocyte chemoattractant protein 1-mediated migration of mesenchymal stem cells is a source of intimal hyperplasia.
Grudzinska MK; Kurzejamska E; Hagemann N; Bojakowski K; Soin J; Lehmann MH; Reinecke H; Murry CE; Soderberg-Naucler C; Religa P
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1271-9. PubMed ID: 23599443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
